Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer
To determine feasibility of using the Computer Assisted Survivor Screening (CASS) as a
routine screening measure for the survivor population. Specifically, to determine patient
acceptance, time to completion, and burden associated with the CASS. To examine the
potential utility of the CASS as a routine screening measure in the survivor population. To
validate the CASS against the SCL-90-R screening measure. Calculate the
sensitivity,specificity, positive and negative predictive values, diagnostic agreement and
ROC curve of the CASS compared to the SCL-90. Determine the optimal cut-off scores to
optimize agreement between the CASS and the SCL-90.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Jennifer Ford, PhD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Food and Drug Administration
04-098
NCT00579293
August 2004
July 2008
Name | Location |
---|---|
Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |